Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 37Myelodysplastic Syndromes 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 11Hematologic Neoplasms 10Lymphoma 9Hodgkin Disease 9Anemia, Refractory, with Excess of Blasts 9Myeloproliferative Disorders 8Multiple Myeloma 8Lymphoma, Non-Hodgkin 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Biphenotypic, Acute 7Graft vs Host Disease 7Leukemia, Lymphocytic, Chronic, B-Cell 6Primary Myelofibrosis 5Neuroblastoma 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid 4Congenital Abnormalities 4Anemia, Aplastic 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Polycythemia Vera 3Lymphoproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1cedazuridine 1Therapeutics 1Specimen Handling 1Pluvicto 1Peripheral Blood Stem Cell Transplantation 1Interleukin-8 1HuMax-IL8 1Granulocyte Colony-Stimulating Factor 1Genetic Counseling 1Filgrastim 1Exercise 1Emapalumab 1Decitabine 1DNA 1Cyclophosphamide 1Busulfan 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytopenia × Busulfan × 1 year × Clear all
NCT02143830 2025-11-12

RAFA

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting
70 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Fanconi Anemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡